Active Systemic Lupus Erythematosus
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB08879 | Belimumab | A B-lymphocyte stimulator (BLyS)-specific inhibitor used to treat systemic lupus erythematosus and active lupus nephritis as an add-on therapy. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB08879 | Belimumab | Tumor necrosis factor ligand superfamily member 13B | target |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB16149 | Efavaleukin alfa | 2 | Terminated | 1 |
| DB11976 | Anifrolumab | 3 | Active Not Recruiting | 1 |
| DB11976 | Anifrolumab | 3 | Completed | 3 |